KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $533.6 million.

  • Chemed's Total Non-Current Liabilities rose 250.87% to $533.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $533.6 million, marking a year-over-year increase of 250.87%. This contributed to the annual value of $536.2 million for FY2024, which is 201.07% down from last year.
  • Chemed's Total Non-Current Liabilities amounted to $533.6 million in Q3 2025, which was up 250.87% from $506.1 million recorded in Q2 2025.
  • Chemed's Total Non-Current Liabilities' 5-year high stood at $709.8 million during Q4 2021, with a 5-year trough of $485.6 million in Q2 2021.
  • Its 5-year average for Total Non-Current Liabilities is $554.7 million, with a median of $533.6 million in 2025.
  • In the last 5 years, Chemed's Total Non-Current Liabilities surged by 3988.07% in 2021 and then crashed by 1497.39% in 2023.
  • Chemed's Total Non-Current Liabilities (Quarter) stood at $709.8 million in 2021, then decreased by 11.08% to $631.2 million in 2022, then dropped by 13.3% to $547.2 million in 2023, then fell by 2.01% to $536.2 million in 2024, then fell by 0.49% to $533.6 million in 2025.
  • Its Total Non-Current Liabilities stands at $533.6 million for Q3 2025, versus $506.1 million for Q2 2025 and $531.7 million for Q1 2025.